Latest Breaking News On - Gastrointestinal research at sarah cannon institute - Page 1 : comparemela.com

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoMatthew deyoungMeredith pelsterDouglase onsiZev wainbergDrug administrationLeap therapeutics incAmerican society of clinical oncologyGi oncology programPrnewswire leap therapeutics incGastrointestinal research at sarah cannon institutePresent new clinical dataDefiance studyClinical oncology

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced.

San franciscoUnited statesUnited kingdomZev wainbergDouglase onsiMatthew deyoungMeredith pelsterDrug administrationPrnewswire leap therapeutics incAmerican society of clinical oncologyGi oncology programGastrointestinal research at sarah cannon instituteLeap therapeutics incClinical oncologyGastrointestinal cancers symposiumAssistant director